Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

5 Best- And Worst-Performing Large-Cap Stocks In Q2 2022

Published 07/15/2022, 12:47 AM
Updated 05/14/2017, 06:45 AM

Recession fears and interest rate hikes from the Federal Reserve weighed on stock market performance during the second quarter. Global uncertainty, rising inflation, and supply shocks resulted in the weakest first-half performance since 1970. Almost all sectors and types of stocks faced challenges during the quarter. Although this isn’t good news for investors, it does offer an opportunity to buy quality stocks at a discount. In descending order, let’s look at the five best- and worst-performing large-cap stocks in Q2 2022.

The Five Best-Performing Large-Cap Stocks In Q2 2022

We used the quarterly return data on large-cap stocks from finviz.com to determine the five best- and worst-performing large-cap stocks in Q2 2022. First, let’s take a look at the five best-performing large-cap stocks in Q2 2022:

  1. AT&T (15%)

Founded in 1983 and headquartered in Dallas, Texas, AT&T (NYSE:T) is a telecommunications company and the biggest provider of mobile telephone services in the U.S. AT&T shares are up by over 10% year to date. Still, they are down almost 5% in the last year. As of this writing, AT&T shares are trading above $20, giving the company a market cap of more than $140 billion. The shares have a 52-week range of $16.62 to $21.61.

  1. Monster Beverage (16%)

Founded in 1990 and headquartered in Corona, California, this company develops and sells energy drinks, beverages, and concentrates. Monster Beverage Corp (NASDAQ:MNST) shares are up by almost 1% year to date and up by over 3% in the last year. As of this writing, Monster Beverage shares are trading at more than $95, giving the company a market cap of more than $51 billion. The shares have a 52-week range of $71.78 to $99.89.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  1. Biohaven Pharmaceutical (23%)

Developed in 2013 and headquartered in New Haven, Connecticut, Biohaven is a clinical-stage biopharmaceutical company developing late-stage drug candidates targeting neurological diseases, including rare disorders. Biohaven Pharmaceutical Holding (NYSE:BHVN) shares are up by over 5% year to date and up by over 20% in the last year. As of this writing, Biohaven Pharmaceutical shares are trading at over $144, giving the company a market cap of more than $10 billion. The shares have a 52-week range of $79.01 to $151.51.

  1. Seagen (25%)

Founded in 1997 and headquartered in Bothell, Washington, Seagen (NASDAQ:SGEN)) is a biotechnology company that develops antibody-based therapies for the treatment of cancer. Seagen shares are up by almost 15% year to date and over 23% in the last year. As of this writing, Seagen shares are trading at over $175, giving the company a market cap of more than $32 billion. The shares have a 52-week range of $105.43 to $192.79.

  1. United Therapeutics (34%)

Founded in 1996 and headquartered in Silver Spring, Maryland, United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company that develops products for chronic and life-threatening diseases. United Therapeutics shares are up by almost 10% year to date and almost 29% in the last year. As of this writing, United Therapeutics shares are trading at over $230, giving the company a market cap of more than $10 billion. The shares have a 52-week range of $158.38 to $245.48.

The Five Worst-Performing Large-Cap Stocks In Q2 2022

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Here are the five worst-performing large-cap stocks in Q2 2022:

  1. Netflix (-54%)

Founded in 1997 and headquartered in Los Gatos, California, Netflix is a streaming entertainment service company. Netflix (NASDAQ:NFLX) shares are down by almost 71% year to date and down by over 67% in the last year. As of this writing, Netflix shares are trading at over $174, giving the company a market cap of more than $77 billion. The shares have a 52-week range of $162.71 to $700.99.

  1. Block (-56%)

Founded in 2009 and headquartered in San Francisco, California, this company helps sellers grow their businesses by providing them with an integrated ecosystem of commerce solutions, business software, and banking services. Block (NYSE:SQ) shares are down by over 60% year to date and down almost 73% in the last year. As of this writing, Block shares are trading at over $63, giving the company a market cap of more than $37 billion. The shares have a 52-week range of $56.01 to $289.23.

  1. Unity Software (-64%)

Founded in 2004 and headquartered in San Francisco, California, this company offers solutions to develop, operate and monetize interactive, real-time 2D and 3D content for all devices. Unity Software (NYSE:U) shares are down by over 77% year to date and down by over 66% in the last year. As of this writing, Unity Software shares are trading at over $32, giving the company a market cap of more than $11 billion. The shares have a 52-week range of $29.09 to $210.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  1. Snap (-64%)

Founded in 2010 and headquartered in Santa Monica, California, Snap is a camera application that allows users to communicate visually with friends and family. Snap (NYSE:SNAP) shares are down by almost 71% year to date and down by over 77% in the last year. As of this writing, Snap shares are trading at over $13, giving the company a market cap of more than $22 billion. The shares have a 52-week range of $11.88 to $83.34.

  1. Cloudflare (-65%)

Founded in 2009 and headquartered in San Francisco, California, this company offers cloud-based services to secure websites. Cloudflare (NYSE:NET) shares are down by over 64% year to date and down by over 54% in the last year. As of this writing, Cloudflare shares are trading at over $46, giving the company a market cap of more than $15 billion. The shares have a 52-week range of $38.96 to $221.64.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.